William Norberg*
Pediatric Cardiac Intensivist President and Medical Researcher at System Medical Inc., McAllen, Texas, United States
*Corresponding Author: William Norberg, Pediatric Cardiac Intensivist President and Medical Researcher at System Medical Inc., McAllen, Texas, United States.
Received: May 02, 2025; Published: June 05, 2025
Hypoalbuminemia has been associated with higher mortality and morbidity in all patients in all ages for all diseases. This was first reported in 1970 these findings remain unchanged today. Attempts at correction of hypoalbuminemia with albumin infusion have all failed treatment of hypoalbuminemia is not recommended without signs or symptoms drug disease hey treatment with a modified albumin product resulted in improvement and prompt discharge of all patients OK.
Citation: William Norberg. “Treatment of Hypoalbuminemia by a Novel Albumin Product". Acta Scientific Clinical Case Reports 6.7 (2025): 07-08.
Copyright: © 2025 William Norberg. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Open Access by
Acta Scientific is licensed under a Creative Commons Attribution 4.0 International License
Based on a work at https://actascientific.com
ff
